... previous lines of therapy. During the study period, 49.0% (50/102) of patients deceased. Additional MTB-based treatment recommendations were achieved in a majority of 68.6% (70/102) of patients, with a recommendation for targeted therapy in 64.3% (45/70) of these patients. Only 6.7% (3/45) of patients...

... carcinoma Advanced renal cell carcinoma Targeted therapy Prognosis Antitumor drugs are approved based on the data from clinical trials in cancer. In metastatic renal cell carcinoma (mRCC), previous trials demonstrated efficacy and safety of molecular-targeted therapy, including tyrosine kinase...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Prostate cancer Targeted therapy...

... in late-onset hypogonadism (LOH). The aim of this study was to investigate the prevalence of LOH in patients with localized RCC (loRCC) and metastatic RCC (mRCC) disease under targeted therapy (TT) and compare the results to findings of epidemiologic studies. Methods: A total of 51 mRCC patients under TT...

...Bernhard Ralla; Barbara Erber; Irena Goranova; Amelie Klooker; Andreas Maxeiner; Stefan Hinz; Carsten Kempkensteffen; Ahmed Magheli; Kurt Miller; Jonas Busch Objectives: Current evidence of sequence-targeted therapy (TT) for patients with metastatic renal cell carcinoma (mRCC) beyond fourth-line...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Renal cell carcinoma Relative survival SEER Targeted therapy Renal cell carcinoma (RCC) accounts for approximately 2-3% of all malignancies with 64,770 new cases and 13,570 deaths...

... targeted therapies in bladder and testicular cancers are still more or less limited to single-case experiences. The great theoretical potential and the multitude of possible targets and drug combinations, however, support further research into this exciting field of medical treatment of urologic...